Johnson and Johnson News
News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.
3 hrs ago | Business Journal
A surgical device maker on Wednesday issued a voluntary worldwide recall of its products because of the risk of spreading undetected cancer.
7 hrs ago | Ledger-Enquirer.com
In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them.
7 hrs ago | Business Journal
Seattle cancer drug-maker Dendreon has named 71-year-old retired biotech executive W. Thomas Amick as the company's new CEO.
9 hrs ago | The Montreal Gazette
In a complicated ruling this month, Superior Court Judge Donald Bisson quashed two separate sales of 47,088 tubes of Polysporin ointment - one of them to the Jean Coutu pharmacy chain - on the grounds the goods transacted never really belonged to the parties selling them.
13 hrs ago | BioResearch Online
Johnson & Johnson company Janssen Research and Development announced that it is has entered into collaboration with bioprinting firm Organovo to investigate 3D printing of living tissue for drug discovery and research.
16 hrs ago | Adrants
Without admitting the ingredients formaldehyde and 1,4-dioxane, present in 100 of its baby products, Johnson's Baby, which earlier this year began introducing reformulated products, is out with a delightfully fuzzy, feel good campaign touting the removal of those ingredients.
18 hrs ago | Freshnews
Milestone Scientific Inc. , a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.
Branded content is not an "if" for marketers; it's a must-have, says Eric Weisberg, Executive Creative Director at JWT , in an interview with Beet.TV.
Closing out a month that included a landmark deal with Apple, IBM is boosting its board of directors with two new additions who are seasoned chief executives.
There are multiple ways to fund or supplement your expenses in retirement - selling part of your retirement portfolio each year, getting a reverse mortgage if you own your home, buying high-yielding dividend stocks, owning bonds, etc.
CTLT is a leader in a field with massive barriers to entry; and has done particularly well under Blackstone's leadership .
TECHNOLOGY. Last year, the Pentagon struck a deal with wireless carriers to give them a coveted band of spectrum for commercial use.
Management has not lost focus. Merck has a plan to attack and grow its share in immuno-oncologyand entering/dominating the hepatitis C and vaccines market.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .
Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.
Updated: Wed Jul 30, 2014 08:56 pm
Copyright © 2014 Topix LLC